What is the recommended treatment approach for a patient diagnosed with Melasma, considering potential hormonal influences and the need for effective management of hyperpigmentation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Melasma Treatment

Start with triple combination cream (hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%) applied once daily combined with strict photoprotection using SPF 50+ broad-spectrum sunscreen reapplied every 2-3 hours. 1, 2

First-Line Treatment Protocol

Photoprotection (Essential Foundation)

  • Apply broad-spectrum sunscreen with minimum SPF 50+ every morning and reapply every 2-3 hours during outdoor exposure 1, 3
  • Wear wide-brimmed hats (>3-inch brim) when outdoors 1, 3
  • Seek shade during peak UV hours (10 a.m. to 4 p.m.) 1, 3
  • Use UV-protective clothing with tight weave fabrics and darker colors 1, 3
  • Completely avoid tanning beds and sunlamps 1, 3

Critical pitfall: Patients commonly forget to reapply sunscreen after swimming, sweating, or after 2-3 hours of continuous exposure—this single failure can undermine all other treatments. 1, 3

Topical Therapy

  • Triple combination cream is FDA-approved and most effective: hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01% applied once daily 1, 2, 4
  • In clinical trials, 77% of patients were clear or almost clear by week 8, with 81-94% achieving clear/mild status by 12 months 4
  • Continue daily application for 12 weeks minimum 5
  • If clear or almost clear at 12 weeks, attempt maintenance dosing twice weekly 5
  • Important caveat: Most patients (approximately 78%) who switch to maintenance therapy will relapse and require return to daily dosing 5

Addressing Hormonal Influences

  • Counsel patients to discontinue oral contraceptives if medically appropriate 6
  • Avoid hormone replacement therapy when possible 6
  • Counsel patients to avoid smoking, which worsens melasma 1, 3

Second-Line Treatment for Inadequate Response After 12 Weeks

Intradermal Platelet-Rich Plasma (PRP) Injections

If melasma persists despite 12 weeks of triple combination cream and strict photoprotection, add intradermal PRP injections. 1, 3

  • Administer 4 treatment sessions spaced every 2-3 weeks 1
  • Inject intradermally at 1 cm intervals across affected areas 1
  • Evaluate response one month after the last treatment 1
  • PRP demonstrates superior efficacy compared to intradermal tranexamic acid injections with similar side effect profiles 3
  • Significant improvement occurs within 6 weeks as measured by modified Melasma Area and Severity Index (mMASI) scores 1, 3
  • Continue triple combination cream and photoprotection during PRP treatment 1

Adjunctive Oral Tranexamic Acid

  • Consider adding oral tranexamic acid 250 mg twice daily, particularly when combined with PRP injections 1, 3
  • PRP combined with oral tranexamic acid shows higher total efficacy (90.48%) compared to tranexamic acid alone (73.68%) with lower disease recurrence rates 1, 3

Alternative Procedural Option

  • Microneedling may be more effective than intradermal PRP injections in some patients 1, 3, 7
  • Consider microneedling as an alternative if PRP is unavailable or ineffective 1
  • Radiofrequency microneedling requires three treatment sessions spaced at least 21 days apart 3

Long-Term Management

Maintenance Therapy

Melasma is a chronic condition with high recurrence rates requiring indefinite maintenance. 1, 3

  • Maintenance treatments every 6 months are typically required 1, 3
  • Continue strict photoprotection indefinitely 1, 3
  • Most patients cannot successfully discontinue daily topical therapy without relapse 5

Monitoring Treatment Success

  • Use standardized mMASI scores to objectively track improvement 1, 3
  • Decreases in MASI >60-90% indicate moderate improvement 1, 3
  • Decreases in MASI >90% indicate excellent response 1, 3
  • Patient satisfaction assessment should complement objective measurements 3

Critical Pitfalls to Avoid

  • Discontinuing treatment too early: Melasma requires long-term maintenance therapy; stopping treatment leads to recurrence 1
  • Inadequate photoprotection: Even excellent topical therapy fails without strict sun protection 1, 3
  • Failing to address hormonal influences: Oral contraceptives and hormone replacement therapy may limit treatment success 1
  • Expecting permanent cure: Patients must understand melasma is chronic and requires ongoing management 1, 3

References

Guideline

Melasma Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Melasma Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Usefulness of retinoic acid in the treatment of melasma.

Journal of the American Academy of Dermatology, 1986

Guideline

Melasma Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.